The Mito-Frail Trial: Effects of MitoQ on Vasodilation, Mobility and Cognitive Performance in Frail Older Adults

NCT06027554 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Frailty
Mild Cognitive Impairment
Aging

Interventions

DRUG: Mitoquinone Mesylate
DIETARY_SUPPLEMENT: Placebo capsule

Sponsor

UConn Health

Collaborators

[object Object]
[object Object]